First-in-human study of JNJ-67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome.
Narayan R, Piérola AA, Donnellan WB, Yordi AM, Abdul-Hay M, Platzbecker U, Subklewe M, Kadia TM, Alonso-Domínguez JM, McCloskey J, Bradford K, Curtis M, Daskalakis N, Guttke C, Safer K, Hiebert B, Murphy J, Li X, Duchin K, Esteban D.
Narayan R, et al. Among authors: murphy j.
Clin Transl Sci. 2024 Mar;17(3):e13742. doi: 10.1111/cts.13742.
Clin Transl Sci. 2024.
PMID: 38494922
Free PMC article.
Clinical Trial.